Ruxolitinib in the Treatment of Polycythemia Vera: Patient Selection and Special Considerations
In a meta-analysis, researchers concluded that ruxolitinib’s place in current practice should be directed toward disease-related symptoms relief after failure of standard treatment.
Journal of Blood Medicine
In The Literature
Bone Marrow Transplantation European Journal of Haematology